We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Nobel Prize winner who discovered the cause of cervical cancer in humans
Isle of Man’s GLO wants to sell 25 per cent to clients, letting them influence production
Error prompts life assurance customers to pause or review relationship with early detection biotech
Marketing attractive nicotine products to children risks a whole generation’s health
Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans
The leaked draft of the WHO Pandemic Accord contains worrying signs
Policy prescriptions are plentiful but momentum and money behind them is lacking
Health official’s admission undermines Beijing’s dismissals that virus could have emerged from Wuhan facility
Government seeks to win over pharma groups with new investments in genomics research and drug manufacturing
As McDonald’s is targeted, governments also need to tighten and enforce rules
Neurotechnology restores natural gait with device that decodes brain’s signals for people with spinal injuries
The organ recovery technique has provoked criticism from within the scientific community
Investors are pouring billions into companies claiming they can analyse DNA to find the disease early. But some scientists question if they really work
Alzheimer’s advocates call for ambitious declaration to match the scope of commitments made 10 years ago
Shadow health secretary sets out plan to boost clinical research
From India to Britain, we have always managed to get in the way of our own inventiveness
Viral disease previously known as monkeypox has caused more than 87,000 infections and 140 deaths
One in 5 biomedical articles may contain faked data, with Chinese paper mills leading way
Project discovers more variation in DNA than expected, offering insights into human diversity
In clinical trials, the medications slowed the progress of the degenerative disease that affects 50mn worldwide
UN health body declares end to acute phase of pandemic after at least 20mn deaths
Biggest biomedical charity makes first investment in science infrastructure from its endowment
The FT’s fourth annual ranking of the region’s businesses by revenue growth. Plus: companies with the ‘last-mover advantage’; cannabis corporations on the rise; is Moderna a one trick pony?
FDA gives green light to C. difficile treatment in boost for microbiome drug developers
Decision halts limitations imposed by a Texas judge earlier this month
International Edition
